Colorado
|
(3990)
|
84-1463284
|
||
(State
or jurisdiction of
|
(Primary
Standard Industrial
|
(I.R.S.
Employer
|
||
incorporation
or organization)
|
Classification
Code Number)
|
Identification
No.)
|
Part
I
|
||||
Page
|
||||
Item
1
|
Financial
Statements
|
3
|
||
Condensed
Balance Sheets (unaudited)
|
3
|
|||
Condensed
Statements of Operations (unaudited)
|
4
|
|||
Condensed
Statements of Cash Flows (unaudited)
|
5
|
|||
Notes
to the Condensed Financial Statements (unaudited)
|
7
|
|||
Item
2
|
Management’s
Discussion and Analysis of
|
|
||
Financial
Condition and Results of Operations
|
13
|
|||
Overview
|
13
|
|||
Intellectual
Property
|
14
|
|||
Critical
Accounting Policies
|
14
|
|||
Liquidity
and Capital Resources
|
15
|
|||
Results
of Operations
|
16
|
|||
Item
3
|
Controls
and Procedures
|
18
|
||
|
||||
Part
II
|
|
|||
|
||||
Item
1
|
Legal
Proceedings.
|
19
|
||
Item
2
|
Changes
in Securities
|
19
|
||
Item
3
|
Defaults
Upon Senior Securities
|
19
|
||
Item
4
|
Submission
of Matters to a Vote of Security Holders
|
19
|
||
Item
5
|
Other
Information
|
20
|
||
Item
6
|
Exhibits
and Reports on Form 8-K
|
20
|
||
Signatures
|
21
|
|||
Exhibits
|
|
September
30, 2007
(Unaudited)
|
December
31, 2006
|
||||||
Assets
|
|||||||
Current
Assets
|
|||||||
Cash
and cash equivalents
|
$
|
115,487
|
$
|
570,501
|
|||
Accounts
receivable, net of allowance of $5,328 at September 30, 2007 and
December
31, 2006
|
53,889
|
11,295
|
|||||
Inventory
|
1,088,305
|
2,125,735
|
|||||
Prepaid
expenses and other current assets
|
152,865
|
141,474
|
|||||
Total
Current Assets
|
1,410,546
|
2,849,005
|
|||||
Property
and Equipment, net of accumulated depreciation of $141,304 at September
30, 2007 and $119,057 at December 31, 2006
|
40,322
|
102,239
|
|||||
Other
Assets
|
|||||||
Note
receivable
|
97,500
|
115,000
|
|||||
Technology
rights, net of accumulated amortization of $511,622 at September
30, 2007
and $332,843 at December 31, 2006
|
4,381,121
|
4,509,900
|
|||||
Patent
costs, net of accumulated amortization
|
627,049
|
582,965
|
|||||
Other
assets
|
21,634
|
22,173
|
|||||
Total
Other Assets
|
5,127,304
|
5,230,038
|
|||||
Total
Assets
|
$
|
6,578,172
|
$
|
8,181,282
|
|||
Liabilities
and Stockholders’ Equity
|
|||||||
Current
Liabilities
|
|||||||
Accounts
payable and other payables
|
$
|
274,076
|
$
|
480,960
|
|||
Preferred
stock dividends payable
|
7,554
|
27,353
|
|||||
Accrued
expenses
|
192,633
|
132,914
|
|||||
Accrued
compensation
|
63,916
|
85,000
|
|||||
Deferred
revenue
|
4,983
|
8,260
|
|||||
Convertible
notes payable, net of discounts of $112,362 at September 30, 2007
and
$52,439 at December 31, 2006
|
1,537,638
|
947,561
|
|||||
Total
Current Liabilities
|
2,080,800
|
1,682,048
|
|||||
Long
term notes payable
|
1,100,000
|
-
|
|||||
Long
term convertible notes payable, net of discounts of $0.00 at September
30,
2007 and $253,303 at December 31, 2006
|
-
|
396,697
|
|||||
Total
Liabilities
|
3,180,800
|
2,078,745
|
|||||
Commitments
(Note 7)
|
-
|
-
|
|||||
Stockholders'
Equity
|
|||||||
Preferred
stock, par value $0.001; 10,000,000 shares authorized
|
|||||||
Convertible
Series A, Preferred stock, 5,000,000 shares authorized, 75,543
shares
|
|||||||
and
90,543 shares outstanding at September 30, 2007 and December 31,
2006,
|
|||||||
respectively;
liquidation preference of $75,543 at September 30, 2007
|
76
|
91
|
|||||
Convertible
Series B preferred stock, 30,000 shares authorized, no shares issued
at
September 30, 2007 and December 31, 2006, respectively.
|
|||||||
Convertible
Series C preferred stock, 10,00 shares authorized, no shares Issued
at September 30, 2007
|
-
|
-
|
|||||
Common
stock, par value $0.001; 200,000,000 shares authorized,
|
|||||||
151,705,295
and 147,127,238 shares issued and outstanding at
|
|||||||
September
30, 2007 and December 31, 2006, respectively
|
151,698
|
147,127
|
|||||
Common
stock issuable, at par value, 1,153,846 shares
|
1,154
|
-
|
|||||
Additional
paid-in capital
|
49,785,178
|
48,926,371
|
|||||
Accumulated
deficit
|
(46,540,734
|
)
|
(42,971,052
|
)
|
|||
Total
Stockholders' Equity
|
3,397,372
|
6,102,537
|
|||||
Total
Liabilities and Stockholders' Equity
|
$
|
6,578,172
|
$
|
8,181,282
|
For
the three months ended
September
30,
|
For
the nine months ended September 30,
|
||||||||||||
2007
|
2006
|
2007
|
2006
|
||||||||||
Revenues
|
$
|
20,531
|
$
|
84,145
|
$
|
145,195
|
$
|
148,950
|
|||||
Cost
of Revenues
|
10,272
|
327,131
|
1,188,135
|
772,836
|
|||||||||
Gross
Profit
|
10,259
|
(242,986
|
)
|
(1,042,940
|
)
|
(623,886
|
)
|
||||||
Operating
Expenses
|
|||||||||||||
Selling,
general and administrative
|
437,728
|
759,054
|
1,222,347
|
5,578,666
|
|||||||||
Research
and development
|
230,748
|
516,485
|
879,652
|
2,051,935
|
|||||||||
Restructuring
costs
|
-
|
-
|
0
|
13,967
|
|||||||||
Bad
debt
|
-
|
-
|
3,995
|
-
|
|||||||||
Total
Operating Expenses
|
668,476
|
1,275,539
|
2,105,994
|
7,644,568
|
|||||||||
Loss
from Operations
|
(658,217
|
)
|
(1,518,525
|
)
|
(3,148,934
|
)
|
(8,268,454
|
)
|
|||||
Other
Income (Expense)
|
|||||||||||||
Other
income
|
50,423
|
2,965
|
74,081
|
30,139
|
|||||||||
Other
expense
|
(12,923
|
)
|
|||||||||||
Settlement
gain (loss), net
|
-
|
175,000
|
-
|
(2,489,507
|
)
|
||||||||
Change
in fair value of warrant liability
|
-
|
2,039,181
|
-
|
3,718,543
|
|||||||||
Intrinsic
value of convertible debt and amortization of debt
discount
|
(64,459
|
)
|
(158,489
|
)
|
(281,165
|
)
|
(2,358,217
|
)
|
|||||
Interest
expense
|
(80,448
|
)
|
(819,385
|
)
|
(200,741
|
)
|
(1,504,089
|
)
|
|||||
Total
Other Income (Expense), Net
|
(94,484
|
)
|
1,239,272
|
(420,748
|
)
|
(2,603,131
|
)
|
||||||
Net
Loss
|
(752,701
|
)
|
(279,253
|
)
|
(3,569,682
|
)
|
(10,871,585
|
)
|
|||||
Preferred
Stock Dividends
|
-
|
49,794
|
-
|
(49,926
|
)
|
||||||||
Net
Loss Available to Common Stockholders
|
$
|
(752,701
|
)
|
$
|
(229,459
|
)
|
$
|
(3,569,682
|
)
|
$
|
(10,921,511
|
)
|
|
Basic
and Diluted Loss Per Common Share Available to Common
Stockholders
|
$
|
(0.00
|
)
|
$
|
(0.00
|
)
|
$
|
(0.02
|
)
|
$
|
(0.10
|
)
|
|
Weighted
average common shares outstanding
|
150,984,050
|
130,287,737
|
149,469,095
|
106,641,991
|
For
the nine months ended
September
30,
|
|||||||
2007
|
2006
|
||||||
CASH
FLOWS FROM OPERATING ACTIVITIES:
|
|||||||
Net
Loss
|
$
|
(3,569,682
|
)
|
$
|
(10,871,585
|
)
|
|
Adjustments
to reconcile net loss to net cash used in operating
activities:
|
|||||||
Stock,
warrants and notes issued for compensation and services
|
49,453
|
2,123,676
|
|||||
Change
in fair value of warrant liability
|
-
|
(3,718,543
|
)
|
||||
Non-cash
interest expense, including intrinsic value of convertible debt and
amortization of debt discount
|
281,166
|
2,358,216
|
|||||
Non-cash
gain on settlement, net
|
-
|
2,629,984
|
|||||
Bad
debt expense
|
3,995
|
2,333
|
|||||
Amortization
of technology rights
|
178,779
|
123,006
|
|||||
Amortization
of patent costs
|
7,624
|
-
|
|||||
Amortization
of deferred consulting and compensation
|
-
|
258,223
|
|||||
Amortization
of deferred financing fees
|
-
|
381,050
|
|||||
Loss
on disposal of assets
|
12,353
|
-
|
|||||
Impairment
of inventory
|
1,046,233
|
-
|
|||||
Compensation
expense payable in common stock
|
18,748
|
328,541
|
|||||
Depreciation
|
40,866
|
94,500
|
|||||
Other
|
-
|
4,413
|
|||||
(Increase)
decrease in assets:
|
|||||||
Accounts
receivable and other receivables
|
(46,589
|
)
|
(133,973
|
)
|
|||
Notes
receivable
|
17,500
|
-
|
|||||
Inventory
|
(8,803
|
)
|
(2,085,000
|
)
|
|||
Prepaid
expenses and other current assets
|
(11,391
|
)
|
(9,839
|
)
|
|||
Deposits
and other assets
|
539
|
70,420
|
|||||
Increase
(decrease) in liabilities:
|
|||||||
Accounts
payable and accrued expenses
|
(168,249
|
)
|
1,673,256
|
||||
Deferred
revenues
|
(3,277
|
)
|
(810
|
)
|
|||
NET
CASH USED IN OPERATING ACTIVITIES
|
(2,150,735
|
)
|
(6,772,132
|
)
|
|||
CASH
FLOWS FROM INVESTING ACTIVITIES:
|
|||||||
Investment
in technology rights
|
(50,000
|
)
|
(800,000
|
)
|
|||
Investment
in patents
|
(51,708
|
)
|
(76,375
|
)
|
|||
Proceeds
from sales of fixed assets
|
8,700
|
-
|
|||||
Proceeds
from sales of marketable securities
|
-
|
31,291
|
|||||
Purchase
of property and equipment
|
-
|
(25,150
|
)
|
||||
NET
CASH USED IN INVESTING ACTIVITIES
|
(93,008
|
)
|
(870,234
|
)
|
|||
CASH
FLOWS FROM FINANCING ACTIVITIES:
|
|||||||
Proceeds
from notes and loans payable
|
1,357,500
|
7,294,950
|
|||||
Payments
on notes and loans payable
|
(80,000
|
)
|
(375,475
|
)
|
|||
Proceeds
from sales of common stock and exercise of warrants and options net
of
offering costs
|
511,229
|
181,550
|
|||||
NET
CASH PROVIDED BY FINANCING ACTIVITIES
|
1,788,729
|
7,101,025
|
|||||
NET
INCREASE IN CASH AND CASH EQUIVALENTS
|
(455,014
|
)
|
(541,341
|
)
|
|||
Cash
and Cash Equivalents at Beginning of Year
|
570,501
|
727,141
|
|||||
CASH
AND CASH EQUIVALENTS AT END OF PERIODS
|
$
|
115,487
|
$
|
185,800
|
|||
(continued)
|
For
the nine months ended
|
|||||||
September
30,
|
|||||||
2007
|
2006
|
||||||
SUPPLEMENTAL
DISCLOSURE OF CASH FLOW INFORMATION:
|
|||||||
Income
taxes paid
|
$
|
-
|
$
|
-
|
|||
Interest
paid
|
$
|
118,143
|
$
|
335,039
|
|||
SUPPLEMENTAL
DISCLOSURE OF NON-CASH
|
|||||||
INVESTING
AND FINANCING ACTIVITIES:
|
|||||||
Conversion
of Series A convertible preferred stock to common stock
|
$
|
15
|
$
|
1,610
|
|||
Discount
on debt of convertible notes payable
|
$
|
87,786
|
$
|
3,606,844
|
|||
Accounts
payable converted to notes payable
|
$
|
-
|
$
|
375,475
|
|||
Conversion
of debt to common stock
|
$
|
177,500
|
$
|
9,454,040
|
|||
Technology
rights acquired through issuance of warrants
|
$
|
-
|
$
|
3,520,243
|
|||
Common
stock issued for deferred consulting and compensation and accrued
liabilities payable in common stock
|
$
|
41,333
|
$
|
833,315
|
|||
Other
comprehensive loss from unrealized loss (gain)
|
$
|
-
|
$
|
-
|
|||
Reclassification
of warrants from equity to liabilities
|
$
|
-
|
$
|
5,668,578
|
Three
Months Ended
|
Nine
Months Ended
|
||||||||||||
Number
of Shares
|
Weighted
Avg. Grant-date Fair Value
|
Number
of Shares
|
Weighted
Avg. Grant-date Fair Value
|
||||||||||
Non-vested
stock options at beginning of period
|
-
|
-
|
485,000
|
$
|
0.45
|
||||||||
Granted
during the period
|
-
|
-
|
-
|
-
|
|||||||||
Vested
during the period
|
-
|
-
|
(27,500
|
)
|
$
|
0.33
|
|||||||
Forfeited
during the period
|
-
|
(457,500
|
)
|
-
|
|||||||||
Non-vested
stock options at September 30, 2007
|
-
|
-
|
-
|
-
|
Three
Months Ended
|
Nine
Months Ended
|
||||||||||||||||||
#
of shares
|
|
Weighted
Average Exercise Price
|
|
#
of shares
|
|
Weighted
Average Exercise Price
|
|
Weighted
Average Remaining Contract Life
|
Aggregate
Intrinsic Value
|
||||||||||
Outstanding
at beginning
of period:
|
4,608,500
|
$
|
0.14
|
5,463,500
|
$
|
0.14
|
|||||||||||||
Forfeited
|
(77,500
|
)
|
$
|
0.93
|
(682,500
|
)
|
$
|
0.20
|
|||||||||||
Granted
|
-
|
-
|
-
|
-
|
|||||||||||||||
Exercised
|
-
|
$
|
0.01
|
(250,000
|
)
|
$
|
0.01
|
||||||||||||
Outstanding
at September
30, 2007
|
4,531,000
|
$
|
0.13
|
4,531,000
|
$
|
0.14
|
9.3.1
years
|
$
|
16,165
|
||||||||||
Outstanding
exercisable at
September 30, 2007
|
4,531,000
|
$
|
0.13
|
4,531,000
|
$
|
0.14
|
9.3.1
years
|
$
|
16,165
|
Exhibit
Number
|
Description |
31.1
|
Certification
of Chief Executive Officer pursuant to Exchange Act Rules 13a-15(e)
and
15d-15(e), as adopted pursuant to Section 203 of the Sarbanes-Oxley
Act of
2002.
|
31.2
|
Certification
of Chief Financial Officer pursuant to Exchange Act Rules 13a-15(e)
and
15d-15(e), as adopted pursuant to Section 203 of the Sarbanes-Oxley
Act of
2002.
|
32.1
|
Certification
of Chief Executive Officer pursuant to 18U.S.C. Section 1350, as
adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
32.2
|
Certification
of Chief Financial Officer pursuant to 18U.S.C. Section 1350, as
adopted
pursuant to Section 906 of the Sarbanes-Oxley Act of
2002.
|
OnScreen
Technologies, Inc.
(Registrant)
|
||
|
|
|
by: | /s/ William J. Clough | |
William J. Clough |
||
Chief Executive Officer/Director |
|
|
|
by: | /s/ Cynthia M. Wilson | |
Cynthia M. Wilson |
||
Interim Chief Financial Officer |